Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
64.8 USD | -3.02% | -3.28% | -22.39% |
Apr. 09 | Cytokinetics Insider Sold Shares Worth $2,422,918, According to a Recent SEC Filing | MT |
Apr. 05 | Sector Update: Health Care Stocks Rise Friday Afternoon | MT |
Financials (USD)
Sales 2024 * | 12.11M | Sales 2025 * | 165M | Capitalization | 7B |
---|---|---|---|---|---|
Net income 2024 * | -466M | Net income 2025 * | -353M | EV / Sales 2024 * | 555 x |
Net cash position 2024 * | 276M | Net cash position 2025 * | 606M | EV / Sales 2025 * | 38.8 x |
P/E ratio 2024 * |
-15.1
x | P/E ratio 2025 * |
-21
x | Employees | 423 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.41% |
Latest transcript on Cytokinetics, Incorporated
1 day | +1.91% | ||
1 week | -1.63% | ||
Current month | -4.69% | ||
1 month | -0.89% | ||
3 months | -18.28% | ||
6 months | +109.73% | ||
Current year | -19.97% |
Managers | Title | Age | Since |
---|---|---|---|
Robert Blum
CEO | Chief Executive Officer | 60 | 98-06-30 |
Kari Loeser
CMP | Compliance Officer | - | 21-10-31 |
Stuart Kupfer
CTO | Chief Tech/Sci/R&D Officer | - | 19-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Nancy Wysenski
BRD | Director/Board Member | 66 | 20-11-19 |
Edward Kaye
BRD | Director/Board Member | 75 | 16-05-19 |
Santo Costa
BRD | Director/Board Member | 78 | 10-09-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.44% | 0 M€ | 0.00% | - | |
0.39% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 64.8 | -3.02% | 1 112 185 |
24-04-24 | 66.82 | +1.91% | 807,781 |
24-04-23 | 65.57 | -1.09% | 1,284,335 |
24-04-22 | 66.29 | -1.87% | 1,184,389 |
24-04-19 | 67.55 | +0.82% | 1,607,395 |
Delayed Quote Nasdaq, April 24, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.97% | 7B | |
-1.51% | 104B | |
+3.22% | 97.42B | |
+0.96% | 22.2B | |
-16.53% | 21.23B | |
-8.72% | 18.33B | |
-42.33% | 16.35B | |
-20.09% | 15.06B | |
+5.47% | 13.98B | |
+28.85% | 11.66B |
- Stock Market
- Equities
- CYTK Stock